James H Sondheimer
Overview
Explore the profile of James H Sondheimer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
379
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leidner A, Cai X, Zelnick L, Lee J, Bansal N, Pasch A, et al.
Kidney Med
. 2023 Nov;
5(11):100723.
PMID: 37915961
Rationale & Objective: Heart failure (HF) is an important cause of morbidity and mortality among individuals with chronic kidney disease (CKD). A large body of evidence from preclinical and clinical...
2.
Hall R, Blumenthal J, Doerfler R, Chen J, Diamantidis C, Jaar B, et al.
Am J Kidney Dis
. 2021 May;
78(6):837-845.e1.
PMID: 34029681
Rationale & Objective: Adults with chronic kidney disease (CKD) may be at increased risk of adverse effects from use of potentially inappropriate medications (PIMs). Our objective was to assess whether...
3.
Orlandi P, Xie D, Yang W, Cohen J, Deo R, Ricardo A, et al.
J Am Soc Nephrol
. 2020 Oct;
31(12):2912-2923.
PMID: 33023926
Background: Slopes of eGFR have been associated with increased risks of death and cardiovascular events in a U-shaped fashion. Poor outcomes in individuals with rising eGFR are potentially attributable to...
4.
Anderson A, Xie D, Wang X, Baudier R, Orlandi P, Appel L, et al.
Am J Kidney Dis
. 2020 Sep;
77(1):56-73.e1.
PMID: 32866540
Rationale & Objective: Identification of novel risk factors for chronic kidney disease (CKD) progression may inform mechanistic investigations and improve identification of high-risk subgroups. The current study aimed to characterize...
5.
Orlandi P, Fujii N, Roy J, Chen H, Hamm L, Sondheimer J, et al.
BMC Nephrol
. 2018 Jun;
19(1):150.
PMID: 29940877
Background: Hematuria is associated with chronic kidney disease (CKD), but has rarely been examined as a risk factor for CKD progression. We explored whether individuals with hematuria had worse outcomes...
6.
Grams M, Yang W, Rebholz C, Wang X, Porter A, Inker L, et al.
Am J Kidney Dis
. 2017 Apr;
70(3):337-346.
PMID: 28366517
Background: People with advanced chronic kidney disease are at risk for the development of end-stage renal disease (ESRD), but also many other adverse outcomes, including cardiovascular disease (CVD) events and...
7.
Mehta R, Cai X, Lee J, Scialla J, Bansal N, Sondheimer J, et al.
JAMA Cardiol
. 2016 Jul;
1(5):548-56.
PMID: 27434583
Importance: Levels of fibroblast growth factor 23 (FGF23) are elevated in chronic kidney disease (CKD) and strongly associated with left ventricular hypertrophy, heart failure, and death. Whether FGF23 is an...
8.
Foster M, Coresh J, Hsu C, Xie D, Levey A, Nelson R, et al.
Am J Kidney Dis
. 2016 Mar;
68(1):68-76.
PMID: 26948990
Background: Serum β-trace protein (BTP) and β2-microglobulin (B2M) are independently associated with end-stage renal disease (ESRD) and mortality in the general population and high-risk groups with diabetes or advanced chronic...
9.
Gutierrez O, Parsa A, Isakova T, Scialla J, Chen J, Flack J, et al.
Clin J Am Soc Nephrol
. 2016 Feb;
11(4):653-62.
PMID: 26912553
Background And Objectives: Disorders of mineral metabolism are more common in African Americans with CKD than in European Americans with CKD. Previous studies have focused on the differences in mineral...
10.
Hsu R, Chai B, Roy J, Anderson A, Bansal N, Feldman H, et al.
Am J Kidney Dis
. 2016 Feb;
68(2):193-202.
PMID: 26830447
Background: It is not clear whether the pattern of kidney function decline in patients with chronic kidney disease (CKD) may relate to outcomes after reaching end-stage renal disease (ESRD). We...